HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ahmed Idbaih Selected Research

Hyperthermia

10/2017Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.
1/2017Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ahmed Idbaih Research Topics

Disease

94Neoplasms (Cancer)
03/2024 - 09/2006
62Glioblastoma (Glioblastoma Multiforme)
03/2024 - 11/2007
52Glioma (Gliomas)
01/2023 - 09/2006
10Oligodendroglioma
12/2019 - 08/2008
7Astrocytoma (Pilocytic Astrocytoma)
12/2022 - 11/2009
5Brain Neoplasms (Brain Tumor)
01/2023 - 01/2013
4Histiocytosis
10/2023 - 01/2017
4Necrosis
01/2023 - 01/2018
4Erdheim-Chester Disease
01/2022 - 09/2014
4Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
11/2019 - 07/2004
3Carcinogenesis
12/2018 - 09/2008
2Ganglioglioma
12/2022 - 11/2018
2Pinealoma (Pineoblastoma)
07/2022 - 11/2009
2Lymphoma (Lymphomas)
03/2022 - 01/2012
2COVID-19
09/2021 - 12/2020
2Progressive Multifocal Leukoencephalopathy
07/2021 - 06/2021
2Diabetes Insipidus
09/2019 - 07/2007
2Circulating Neoplastic Cells
01/2018 - 01/2015
2Hyperthermia
10/2017 - 01/2017
1Plexiform Neurofibroma
03/2023
1Neurofibroma
03/2023
1Neurilemmoma (Schwannoma)
03/2023
1Neurofibrosarcoma (MPNST)
03/2023
1Thrombocytopenia (Thrombopenia)
01/2023
1Residual Neoplasm
01/2023
1Hydrocephalus (Hydrocephaly)
07/2022
1Germinoma
07/2022

Drug/Important Bio-Agent (IBA)

26Temozolomide (Temodar)FDA LinkGeneric
03/2024 - 09/2006
20Biomarkers (Surrogate Marker)IBA
10/2023 - 09/2007
12Lomustine (CCNU)FDA Link
10/2023 - 07/2011
11Bevacizumab (Avastin)FDA Link
10/2023 - 09/2008
9Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2023 - 09/2009
9DNA (Deoxyribonucleic Acid)IBA
10/2023 - 05/2010
9Procarbazine (Matulane)FDA Link
06/2017 - 03/2010
8Vincristine (Oncovin)FDA LinkGeneric
06/2017 - 03/2010
7VemurafenibIBA
01/2022 - 09/2014
6Codon (Codons)IBA
01/2017 - 07/2007
6MethyltransferasesIBA
09/2014 - 09/2006
5Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2007
4Carboplatin (JM8)FDA LinkGeneric
02/2024 - 01/2016
4RNA (Ribonucleic Acid)IBA
10/2023 - 11/2009
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2023 - 01/2021
4AntibodiesIBA
01/2023 - 10/2015
4NivolumabIBA
01/2023 - 01/2019
45- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA
12/2021 - 03/2016
4alpha-internexinIBA
11/2011 - 05/2008
3Immune Checkpoint InhibitorsIBA
12/2022 - 07/2021
3EverolimusFDA Link
12/2022 - 01/2015
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2022 - 12/2020
3IronIBA
09/2021 - 01/2017
3Antimitotic AgentsIBA
01/2021 - 12/2015
3ErbB Receptors (EGF Receptor)IBA
02/2020 - 08/2008
3Mitogen-Activated Protein KinasesIBA
12/2019 - 11/2009
3Transcription Factors (Transcription Factor)IBA
01/2018 - 03/2008
3Histones (Histone)IBA
10/2016 - 01/2014
3Irinotecan (Camptosar)FDA LinkGeneric
04/2015 - 09/2008
2marizomibIBA
03/2024 - 01/2021
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2023 - 05/2013
2Phosphotransferases (Kinase)IBA
09/2023 - 07/2015
2GadoliniumIBA
03/2022 - 12/2021
2Tyrosine Kinase InhibitorsIBA
02/2022 - 09/2008
2Angiogenesis InhibitorsIBA
01/2022 - 09/2008
2somatostatin receptor 2IBA
01/2020 - 01/2018
2MicroRNAs (MicroRNA)IBA
12/2018 - 01/2018
2Adenosine Triphosphate (ATP)IBA
07/2018 - 07/2018
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2018 - 07/2018
2Messenger RNA (mRNA)IBA
01/2018 - 11/2010
2ParaffinIBA
09/2014 - 04/2008
2Complement System Proteins (Complement)IBA
09/2014 - 05/2011
2O-(6)-methylguanineIBA
09/2014 - 05/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2014 - 09/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013 - 09/2008
2Alkylating AgentsIBA
11/2007 - 09/2006
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2024
1NeopterinIBA
10/2023
1Eosine Yellowish-(YS) (Eosin)IBA
03/2023
1MTOR InhibitorsIBA
03/2023
1Hematoxylin (Haematoxylon)IBA
03/2023
1AZD 6244IBA
03/2023
1AnthracyclinesIBA
03/2023
1Immune Checkpoint ProteinsIBA
01/2023
1SulfurtransferasesIBA
10/2022
1PolyethyleneimineIBA
10/2022
1Drug CarriersIBA
10/2022
1carbeneIBA
10/2022
1PlatinumIBA
10/2022
1Dihydroxyphenylalanine (Dopa)IBA
09/2022

Therapy/Procedure

42Drug Therapy (Chemotherapy)
03/2024 - 11/2007
33Therapeutics
03/2024 - 07/2004
22Radiotherapy
03/2024 - 09/2010
7Chemoradiotherapy
03/2024 - 05/2011
7Precision Medicine
10/2023 - 11/2015
3Artificial Respiration (Mechanical Ventilation)
09/2021 - 11/2017
2Immunotherapy
12/2023 - 01/2021
2Aftercare (After-Treatment)
01/2020 - 01/2020
2Molecular Targeted Therapy
11/2015 - 09/2008
1Time-to-Treatment
01/2023
1Drug Tapering
01/2023
1Conformal Radiotherapy
12/2022
1Ventriculostomy
07/2022